about
Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in PigletsAnalgesia and sedation in children: practical approach for the most frequent situations.Evaluation of sublingual microcirculation in a paediatric intensive care unit: prospective observational study about its feasibility and utility.Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation studySmart pump alerts: all that glitters is not gold.Developing a drug library for smart pumps in a pediatric intensive care unit.Nutritional status and clinical outcome of children on continuous renal replacement therapy: a prospective observational study.Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.Impact of implementing smart infusion pumps in a pediatric intensive care unit.Implementing smart pump technology in a pediatric intensive care unit: a cost-effective approach.Relationship between hyperglycemia, hormone disturbances, and clinical evolution in severely hyperglycemic post surgery critically ill children: an observational studyRisks in the implementation and use of smart pumps in a pediatric intensive care unit: application of the failure mode and effects analysis.Pediatric defibrillation after cardiac arrest: initial response and outcomeComparison of normal saline, hypertonic saline albumin and terlipressin plus hypertonic saline albumin in an infant animal model of hypovolemic shock.Different Respiratory Rates during Resuscitation in a Pediatric Animal Model of Asphyxial Cardiac ArrestDiffuse persistent pulmonary interstitial emphysema secondary to mechanical ventilation in bronchiolitisNon-invasive mechanical ventilation after heart surgery in children.Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review.Postpyloric enteral nutrition in the critically ill child with shock: a prospective observational study.Gastroesophageal reflux in critically ill children: a review.A child presenting with acute renal failure secondary to a high dose of indomethacin: a case report.Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study.Gastrointestinal complications in critically ill patients: what differs between adults and children?Monitoring sedation in the critically ill child.Development of a compatibility chart for intravenous Y-site drug administration in a pediatric intensive care unit.Preparation of intravenous drug administration guidelines for a pediatric intensive care unit.Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.Infection in critically ill pediatric patients on continuous renal replacement therapy.Incidence and prognosis of nosocomial infection after recovering of cardiac arrest in children.Comparison between pressure-recording analytical method (PRAM) and femoral arterial thermodilution method (FATD) cardiac output monitoring in an infant animal model of cardiac arrest.The role of the gray-to-white matter ratio to predict the prognosis of cardiac arrest treated with ECMOConstipation in the Critically Ill Child: Frequency and Related Factors.Paediatric cardiopulmonary resuscitation training program in Latin-America: the RIBEPCI experience.Assessment of pain in critically ill children. Is cutaneous conductance a reliable tool?In-hospital pediatric cardiac arrest in Honduras.Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study.Is Hydrogen Breath Test with Lactulose Feasible for Measuring Gastrocecal Transit in Critically Ill Children? Pilot Study about Modification of the Technique.Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock.Terlipressin versus adrenaline in an infant animal model of asphyxial cardiac arrest.Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy.
P50
Q28550177-7F3CD017-41BC-45C6-8023-16DF758BB33EQ30361982-269B7DC2-52F7-4729-9387-53ACFE3B35F2Q30842061-4196197B-36CF-4782-A66E-106E95D0764EQ33612787-F279328C-C9F8-4456-9E27-F88031D78817Q34073076-EBC1B43D-CAE1-42AC-9C2F-897D5482299AQ34120894-AAEC7082-3CAC-452F-A958-6A4E580C6CEFQ34422967-F6AF14A5-BCBA-43DA-BB27-3FE90220E98EQ34999286-3BE60BDB-5A19-4D54-8BF5-8FB87E72F11EQ35017807-BA1000AD-5D1A-4608-9C95-46DE3768B876Q35057634-EAB6633D-7F9B-4BE4-AF4F-2E639BFFFD8BQ35120617-AD256E3A-8523-4C73-B733-DF1DE47DB4EBQ35158711-CEBE8089-10DD-4804-BDA0-C589B49AA429Q35544660-9FAE1748-FB1C-4299-9E39-AA32C132BDA8Q35582813-F5A7F3BE-394E-43AE-837C-5966B1F898B6Q36129915-28B98049-253C-42C3-A706-B05E67E15DA8Q36181609-F10BD63A-C90C-4F82-808D-5758EA31C07EQ36207153-6DB19BA9-1E7C-4F1C-A081-C2D4C704BB6CQ36232330-3BDC6361-9F12-48F3-A3D9-9D2720546548Q36488786-C9141772-6347-4717-9C8D-529C7F7410B8Q36610419-916B2817-D380-4DDE-9554-6D55EFF8C828Q37110038-D758C423-9E1B-41F7-A00B-565EBF7C564EQ37343247-17127FAE-DD82-40D9-8CF1-C9340B1627FBQ37388393-FFB887C5-FFA0-41C5-896F-BDC669086C49Q37696532-4A046509-AA80-414D-B843-B849F4B68430Q37989848-83784E24-0F17-4C15-842B-682005FD2B0AQ38175318-2541C2BB-D00D-4C95-9B4F-52B4FBF05BCAQ38650836-25FBDF48-2196-418E-AD1D-B473C8D288CEQ38774319-0EB3FC83-5B3A-4553-9627-F658F7A763BEQ38954948-5B9FFF69-294A-45A8-A9D8-0D0FB106C0A5Q39713778-BD360B60-E865-4748-9492-A77D87D735B6Q40555589-FF7C5B4C-A61B-4E2E-9BCA-0D1B688BF1CDQ40645582-D8930F50-92B9-49FA-8C6C-3885CD858D13Q41172381-E134308E-6EA9-41DB-85B8-6B86C81CE1FDQ41250734-D06C9816-BEF7-4BA7-AA4A-744905877715Q41667567-DB441A4C-5880-4191-B4FD-7F6649A7EA6FQ41839496-707753E9-A320-4174-A4ED-B11676CF8959Q42132744-C5D7E717-E669-4AED-B688-A23EB574EC9EQ42907348-AA8C3D67-42B2-4E2F-AAB6-4009FAE85D12Q43125684-3EA91F9E-CDB4-494D-AABC-63CDC985DDA3Q43125691-EEA92668-84C6-4426-8322-9DDB4D9DE9DF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jesus Lopez-herce
@ast
Jesus Lopez-herce
@en
Jesus Lopez-herce
@es
Jesus Lopez-herce
@nl
Jesus Lopez-herce
@sl
type
label
Jesus Lopez-herce
@ast
Jesus Lopez-herce
@en
Jesus Lopez-herce
@es
Jesus Lopez-herce
@nl
Jesus Lopez-herce
@sl
prefLabel
Jesus Lopez-herce
@ast
Jesus Lopez-herce
@en
Jesus Lopez-herce
@es
Jesus Lopez-herce
@nl
Jesus Lopez-herce
@sl
P106
P1153
26643249900
P21
P2456
P2798
P31
P496
0000-0001-6105-9178